CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Sebastien Ourselin

ORCID: 0000-0002-5694-5340↗

Public evidence

4 connected articles

COVID-19 due to the B.1.617.2 (Delta) variant compared to B.1.1.7 (Alpha) variant of SARS-CoV-2: two prospective observational cohort studies2021 · medRxiv Post-vaccination SARS-CoV-2 infection: risk factors and illness profile in a prospective, observational community-based case-control study2021 · medRxiv Knowledge barriers in the symptomatic-COVID-19 testing programme in the UK: an observational study2021 · medRxiv Anosmia and other SARS-CoV-2 positive test-associated symptoms, across three national, digital surveillance platforms as the COVID-19 pandemic and response unfolded: an observation study2020 · medRxiv

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Sebastien Ourselin - Medical Cannabis Research Engine